Blog
Keep up to date with the latest news from Instem.
Instem achieves a major milestone, acquires all shares of Xybion from Banerjee Group LLC controlled by Dr. Pradip K. Banerjee
Instem has completed its acquisition of Xybion Digital, creator of the Pristima™ preclinical study management platform.
Instem Announces Acquisition of RockStep Solutions, Inc.
Instem Strengthens Preclinical Capabilities with RockStep Acquisition and Climb™ Integration
5 De-Identification Mistakes and How to Avoid Them
In this blog, we discuss five common mistakes researchers make when approaching de-identification and how they can overcome them.
ICH M7: From Guideline to Practical Workflow
Implementing Protocol-Driven (Q)SAR Mutagenicity Assessments for Pharmaceutical Impurities.
Instem Announces Provantis® 12: A Powerful Step Forward in Preclinical Study Management
This release includes significant feature advancements, a new web-based module, and broad support for digital workflow adoption.
5 Reasons Why Clinical Trial Data Workflows Are Moving to the Cloud
This blog will focus on five core reasons why workflows are moving to the cloud and how this benefits researchers. We’ll also talk about the role of solutions in enabling more efficient and compliant clinical...
How to Modernize Your Clinical Data Management and Analytics with Cloud Technology
In this post, we dive into how cloud computing is revolutionizing the management, analysis, and sharing of clinical trial data.
I read all the FDA feedback on Dataset-JSON, so you didn’t have to!
Marc Ellison, Director, Regulatory Solutions, takes a closer look at the FDA feedback on the new CDISC standard: Dataset-JSON v1.1 as a replacement for XPT files.
Introducing Blur™ 2.9: Smarter, Faster Anonymization for Clinical Trial Transparency
As clinical trials transparency needs grow, life sciences teams need more than anonymization—they need a full clinical trial transparency platform.